Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

Scientists at the Institute of Chemistry have developed a new type of contrast agent for magnetic resonance imaging (MRI)—bovine serum albumin nanoparticles doped with manganese (II) ions. The results ...

CAMBRIDGE, Mass. -- A new, specially coated iron oxide nanoparticle developed by a team at MIT and elsewhere could provide an alternative to conventional gadolinium-based contrast agents used for ...

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can ...

MRI contrast agents, which are typically gadolinium-based, are used to enhance visualization of abnormal structures or lesions and to aid differentiation between healthy and pathological tissue. This ...

A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) have found a way to detect metastases in certain types of cancer in the brain at an ...

One of the most widely used drugs in the world isn't really a drug, at least not in the usual sense. It's more like a dye. Physicians call this drug "contrast," shorthand for contrast agent. Contrast ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...